SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-021928
Filing Date
2020-05-06
Accepted
2020-05-06 16:10:43
Documents
13
Period of Report
2020-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nbix-8k_20200506.htm   iXBRL 8-K 51153
2 EX-99.1 nbix-ex991_52.htm EX-99.1 452459
  Complete submission text file 0001564590-20-021928.txt   657830

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nbix-20200506.xsd EX-101.SCH 5784
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbix-20200506_lab.xml EX-101.LAB 18732
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbix-20200506_pre.xml EX-101.PRE 11179
6 EXTRACTED XBRL INSTANCE DOCUMENT nbix-8k_20200506_htm.xml XML 3416
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12780 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

IRS No.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22705 | Film No.: 20852710
SIC: 2836 Biological Products, (No Diagnostic Substances)